Unveiling the Potential of Ent-Kaurane Diterpenoids: Multifaceted Natural Products for Drug Discovery

Shadrack Kibet,Njogu M. Kimani,Syombua S. Mwanza,Cynthia M. Mudalungu,Cleydson B. R. Santos,Chrysantus M. Tanga
DOI: https://doi.org/10.3390/ph17040510
IF: 4.6
2024-04-17
Pharmaceuticals
Abstract:Natural products hold immense potential for drug discovery, yet many remain unexplored in vast libraries and databases. In an attempt to fill this gap and meet the growing demand for effective drugs, this study delves into the promising world of ent-kaurane diterpenoids, a class of natural products with huge therapeutic potential. With a dataset of 570 ent-kaurane diterpenoids obtained from the literature, we conducted an in silico analysis, evaluating their physicochemical, pharmacokinetic, and toxicological properties with a focus on their therapeutic implications. Notably, these natural compounds exhibit drug-like properties, aligning closely with those of FDA-approved drugs, indicating a high potential for drug development. The ranges of the physicochemical parameters were as follows: molecular weights—288.47 to 626.82 g/mol; number of heavy atoms—21 to 44; the number of hydrogen bond donors and acceptors—0 to 8 and 1 to 11, respectively; the number of rotatable bonds—0 to 11; fraction Csp3—0.65 to 1; and TPSA—20.23 to 189.53 Ų. Additionally, the majority of these molecules display favorable safety profiles, with only 0.70%, 1.40%, 0.70%, and 46.49% exhibiting mutagenic, tumorigenic, reproduction-enhancing, and irritant properties, respectively. Importantly, ent-kaurane diterpenoids exhibit promising biopharmaceutical properties. Their average lipophilicity is optimal for drug absorption, while over 99% are water-soluble, facilitating delivery. Further, 96.5% and 28.20% of these molecules exhibited intestinal and brain bioavailability, expanding their therapeutic reach. The predicted pharmacological activities of these compounds encompass a diverse range, including anticancer, immunosuppressant, chemoprotective, anti-hepatic, hepatoprotectant, anti-inflammation, antihyperthyroidism, and anti-hepatitis activities. This multi-targeted profile highlights ent-kaurane diterpenoids as highly promising candidates for further drug discovery endeavors.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
This paper discusses the potential of ent-kaurane diterpenoid compounds as drug candidates. These natural products have various pharmacological activities, including anticancer, immunosuppressive, chemoprotective, and antihepatitis activities. The study collected a dataset of 570 ent-kaurane diterpenoid compounds and performed computer-aided drug property assessments such as physicochemical properties, absorption, distribution, metabolism, excretion, and toxicity (ADMET), and toxicological features. The article points out that the physicochemical properties of these compounds are similar to FDA-approved drugs, demonstrating good drug-like properties such as appropriate molecular weight, number of hydrogen bond donors and acceptors, and polar surface area. In terms of toxicity, most compounds exhibit low toxicity risks, with only a few showing potential genetic toxicity, carcinogenicity, or irritability. In addition, the study found that ent-kaurane diterpenoid compounds have good lipophilicity and aqueous solubility, with most being able to be absorbed through the gastrointestinal tract, but only a few can penetrate the blood-brain barrier. They also have the potential to be targets for various enzymes and receptors, such as GPCR ligands and ion channel modulators. In conclusion, this paper reveals the significant potential of ent-kaurane diterpenoid compounds as multi-target drug candidates, providing valuable information for further drug development.